News
There’s reason to remain bullish about Merck’s growth prospects in the long run. And at a discounted price, the stock could ...
Merck & Co., Inc. (NYSE:MRK) is one of the 11 Best Drug Stocks to Buy According to Hedge Funds. Analyst Asad Haider from ...
Merck has received approval from the Food and Drug Administration to expand use of its blockbuster drug, Keytruda, to treat ...
Merck & Co.’s ambition to get the first oral PCSK9 inhibitor to market came one step closer this morning as the pharma ...
Merck & Co. said it won US approval for a shot that protects against RSV, the most common cause of hospitalization among ...
Merck's Keytruda receives FDA approval for head and neck cancer after showing improved event-free survival in Phase 3 KEYNOTE ...
3d
News-Medical.Net on MSNBenchling and Merck collaborate on vaccine bioanalysisBenchling announced a new collaboration with Merck, known as MSD outside of the United States and Canada, to implement a ...
The Food and Drug Administration has approved a new drug from Merck designed to protect infants from respiratory syncytial ...
The simplicity of Merck's monoclonal antibody for RSV in infants could be a plus in its competition with AstraZeneca's existing treatment.
Merck Manuals, a comprehensive digital health resource, announced today it has launched a new search tool enhanced by artificial intelligence to provide patients and other health care consumers with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results